Literature DB >> 18086499

Studies on the reactivity of organometallic Ru-, Rh- and Os-pta complexes with DNA model compounds.

Antoine Dorcier1, Christian G Hartinger, Rosario Scopelliti, Richard H Fish, Bernhard K Keppler, Paul J Dyson.   

Abstract

The reactions of arene-metal complexes (arene=p-cymene, benzene or pentamethylcyclopentadienyl, metal=Ru, Rh or Os), including 1,3,5-triaza-7-phosphatricyclo-[3.3.1.1]decanephosphine (pta) and chloro co-ligands, with 9-methylguanine, adenine, and a series of nucleosides were studied in water to ascertain the binding modes. The products were characterized by NMR spectroscopy and electrospray ionization mass spectrometry (ESI-MS). Tandem mass spectrometry was found to provide excellent information on preferential binding sites. In general, the N7 position on guanine (the most basic site) was found to be the preferred donor atom for coordination to the metal complexes. The X-ray structures of the precursor complexes, [(eta5-C10H15)RhCl(pta-Me)2]Cl2, [(eta6-C10H14)OsCl(pta)2]Cl, and [(eta6-C6H6)OsCl2(CH3CN)], are also reported.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18086499     DOI: 10.1016/j.jinorgbio.2007.10.016

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  10 in total

1.  Ruthenium versus platinum: interactions of anticancer metallodrugs with duplex oligonucleotides characterised by electrospray ionisation mass spectrometry.

Authors:  Michael Groessl; Yury O Tsybin; Christian G Hartinger; Bernhard K Keppler; Paul J Dyson
Journal:  J Biol Inorg Chem       Date:  2010-03-07       Impact factor: 3.358

2.  Reactivity of hexanuclear ruthenium metallaprisms towards nucleotides and a DNA decamer.

Authors:  Lydia E H Paul; Bruno Therrien; Julien Furrer
Journal:  J Biol Inorg Chem       Date:  2014-11-08       Impact factor: 3.358

3.  Transferring the concept of multinuclearity to ruthenium complexes for improvement of anticancer activity.

Authors:  Maria G Mendoza-Ferri; Christian G Hartinger; Marco A Mendoza; Michael Groessl; Alexander E Egger; Rene E Eichinger; John B Mangrum; Nicholas P Farrell; Magdalena Maruszak; Patrick J Bednarski; Franz Klein; Michael A Jakupec; Alexey A Nazarov; Kay Severin; Bernhard K Keppler
Journal:  J Med Chem       Date:  2009-02-26       Impact factor: 7.446

4.  Physicochemical Studies and Anticancer Potency of Ruthenium η-p-Cymene Complexes Containing Antibacterial Quinolones.

Authors:  Jakob Kljun; Anna K Bytzek; Wolfgang Kandioller; Caroline Bartel; Michael A Jakupec; Christian G Hartinger; Bernhard K Keppler; Iztok Turel
Journal:  Organometallics       Date:  2011-04-06       Impact factor: 3.876

5.  En route to osmium analogues of KP1019: synthesis, structure, spectroscopic properties and antiproliferative activity of trans-[Os(IV)Cl4(Hazole)2].

Authors:  Gabriel E Büchel; Iryna N Stepanenko; Michaela Hejl; Michael A Jakupec; Bernhard K Keppler; Vladimir B Arion
Journal:  Inorg Chem       Date:  2011-07-08       Impact factor: 5.165

6.  Binding mechanisms of half-sandwich Rh(III) and Ru(II) arene complexes on human serum albumin: a comparative study.

Authors:  Orsolya Dömötör; Éva A Enyedy
Journal:  J Biol Inorg Chem       Date:  2019-07-12       Impact factor: 3.358

7.  ESI-MS Study of the Interaction of Potential Oxidovanadium(IV) Drugs and Amavadin with Model Proteins.

Authors:  Valeria Ugone; Daniele Sanna; Giuseppe Sciortino; Debbie C Crans; Eugenio Garribba
Journal:  Inorg Chem       Date:  2020-06-25       Impact factor: 5.165

8.  Sensitive Marker of the Cisplatin-DNA Interaction: X-Ray Photoelectron Spectroscopy of CL.

Authors:  Fangxing Xiao; Xiaobin Yao; Qianhong Bao; Danzhen Li; Yi Zheng
Journal:  Bioinorg Chem Appl       Date:  2012-10-24       Impact factor: 7.778

9.  Altered DNA binding and amplification of human breast cancer suppressor gene BRCA1 induced by a novel antitumor compound, [Ru(η(6)-p-phenylethacrynate)Cl(2)(pta)].

Authors:  Korawan Chakree; Chitchamai Ovatlarnporn; Paul J Dyson; Adisorn Ratanaphan
Journal:  Int J Mol Sci       Date:  2012-10-15       Impact factor: 5.923

10.  NMR studies of group 8 metallodrugs: 187Os-enriched organo-osmium half-sandwich anticancer complex.

Authors:  Russell J Needham; Ivan Prokes; Abraha Habtemariam; Isolda Romero-Canelón; Guy J Clarkson; Peter J Sadler
Journal:  Dalton Trans       Date:  2021-09-28       Impact factor: 4.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.